Aparito is a med-tech company specialising in capturing patient generated data and developing digital endpoints remotely, with an expertise in decentralised / hybrid studies. We provide innovative, patient-centric drug development solutions, integrating specialist clinical and regulatory knowledge with the technology to gather highly relevant patient-generated data outside of the hospital setting, to streamline the drug development process. Aparito is transforming healthcare by unlocking real world patient data through innovative technology.
Elin Haf Davies PhD
Chief Executive Officer
Apartio
Other speakers in 2020
Canada
Prof. Daniel Mueller, MD, PhD
Head, Pharmacogenetics Research Clinic and Staff Psychiatrist, Genaral Adult Psychiatry, Centre for Addiction and Mental Health (CAMH), Toronto
Professor at Department of Psychiatry and Department of Pharmacology & Toxicology , University of Toronto
